Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer

Clinical trial NCT01548677 · COMPLETED

Trial details

NCT number: NCT01548677
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Circulating Tumor Cells

Start date: 2013-04-01
Primary completion: 2017-03-01
Enrollment: 1317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.